Crohn's disease trials in Australia

In Australia 20 Also abroad 422

20 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Where
Adelaide, Brisbane, Clayton, Concord, Melbourne
Age
16 years to 80 years
People
1,200 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00
Phase 3Taking people
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
Where
Nedlands, Parkville, South Brisbane
Age
2 years to 17 years
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07298421 · EU 2025-523318-96-00
Phase 2Taking people
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Where
Bedford Park, Elizabeth Vale, Herston, Kurralta Park, Melbourne, Perth, Woolloongabba, QLD
Age
18 years to 85 years
People
385 worldwide
Run by
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
See details and how to joinNCT06226883 · EU 2023-508158-24-00
No phaseTaking people
Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study
Where
Hobart, Melbourne, Sydney
Age
18 years and over
People
50
Run by
Austin Health
See details and how to joinNCT07916727
Phase 3Taking people
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Where
Nedlands, South Brisbane, Westmead
Age
2 years to 17 years
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT05923073 · EU 2023-504735-41-00
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Nedlands, South Brisbane, Westmead
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 2/3Taking people
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Where
Adelaide, Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, South Brisbane
Age
18 years and over
People
1,092 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07196722 · EU 2025-521382-27-00
Phase 3Taking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Where
Adelaide, Camperdown, Clayton, Kurraba Point, Macquarie Island, Murdoch, New Lambton, South Brisbane, West Melbourne
Age
18 years and over
People
460 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577843 · EU 2026-525922-39-00
Phase 2Taking people
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Where
Bedford Park, Concord, Epping, Footscray, Murdoch, Nedlands, Perth, South Brisbane, Woodville
Age
18 years to 75 years
People
268 worldwide
Run by
Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00
Phase 2Taking people
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Where
Brisbane, Footscray, Kurralta Park
Age
18 years to 75 years
People
99 worldwide
Run by
Sanofi
See details and how to joinNCT06958536 · EU 2024-517016-30-00
Phase 3Taking people
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Where
Adelaide, Footscray, Mackay, Macquarie Park, Parkville, Wahroonga
Age
16 years to 80 years
People
425 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06819891 · EU 2024-513054-30-00
Phase 3Taking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Where
Birtinya, Clayton, Liverpool, Nedlands, South Brisbane, Southport, Wollongong
Age
16 years to 80 years
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184931
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Where
Salzburg, South Brisbane, Vienna
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07184944
Phase 3Taking people
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Where
Adelaide, Epping, Garran, Herston, Murdoch, Perth, South Brisbane, Sydney, Woolloongabba
Age
16 years to 80 years
People
600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Clayton, Parkville, South Brisbane, Westmead
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
Phase 3Taking people
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Where
Clayton, Parkville, South Brisbane, Westmead
Age
2 years to 17 years
People
120 worldwide
Run by
Takeda
See details and how to joinNCT04779320 · EU 2023-509045-13-00
Phase 4Taking people
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Where
Adelaide, Concord, Epping, Heidelberg, Melbourne, Murdoch, South Brisbane, Woodville
Age
18 years to 80 years
People
304 worldwide
Run by
Alimentiv Inc.
See details and how to joinNCT06257706 · EU 2023-509096-16-00
No phaseNot yet taking people in Australia
Use of Water Ingestion in Small Intestine Ultrasound
Where
Heidelberg
Age
18 years to 80 years
People
55
Run by
Austin Health
See details and how to joinNCT07079007
Phase 1/2Taking people
Microbial Restoration in Inflammatory Bowel Diseases
Where
Melbourne
Age
18 years to 70 years
People
120
Run by
St Vincent's Hospital Melbourne
See details and how to joinNCT04970446
No phaseTaking people
The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
Where
Melbourne
Age
18 years to 80 years
People
13
Run by
Austin Health
See details and how to joinNCT05469607